Evidence map›Paper›PMID 36235772›Full record

ArticleNutrients2022

Naringin Ameliorates Skeletal Muscle Atrophy and Improves Insulin Resistance in High-Fat-Diet-Induced Insulin Resistance in Obese Rats.

Chutimon Termkwancharoen, Wachirawadee Malakul, Amnat Phetrungnapha, Sakara Tunsophon

Open access · goldFull text read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Effect ofMedical sciences (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chutimon TermkwancharoenDepartment of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Wachirawadee MalakulDepartment of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Amnat PhetrungnaphaDepartment of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Sakara TunsophonDepartment of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Naresuan University · TH

Funding

the National Research Council of Thailand 2563/6
6 · The paper itself

Abstract

Obesity causes progressive lipid accumulation and insulin resistance within muscle cells and affects skeletal muscle fibres and muscle mass that demonstrates atrophy and dysfunction. This study investigated the effects of naringin on the metabolic processes of skeletal muscle in obese rats. Male Sprague Dawley rats were divided into five groups: the control group with normal diet and the obese groups, which were induced with a high-fat diet (HFD) for the first 4 weeks and then treated with 40 mg/kg of simvastatin and 50 and 100 mg/kg of naringin from week 4 to 8. The naringin-treated group showed reduced body weight, biochemical parameters, and the mRNA expressions of protein degradation. Moreover, increased levels of antioxidant enzymes, glycogen, glucose uptake, the expression of the insulin receptor substrate 1 (IRS-1), the glucose transporter type 4 (GLUT4), and the mRNA expressions of protein synthesis led to improved muscle mass in the naringin-treated groups. The in vitro part showed the inhibitory effects of naringin on digestive enzymes related to lipid and glucose homeostasis. This study demonstrates the potential benefits of naringin as a supplement for treating muscle abnormalities in obese rats by modulating the antioxidative status, regulating protein metabolism, and improved insulin resistance in skeletal muscle of HFD-induced insulin resistance in obese rats.

Indexed as

Diet, High-FatFlavanonesInsulin ResistanceMuscular AtrophyAnimalsAntioxidantsGlucoseGlucose Transporter Type 4GlycogenInsulinInsulin Receptor Substrate ProteinsMaleMuscle, SkeletalObesityRatsRats, Sprague-DawleyAntioxidantsFlavanonesGlucoseGlucose Transporter Type 4GlycogenInsulinInsulin Receptor Substrate ProteinsnaringinRNA, MessengerSimvastatinatrophyhigh-fat dietinsulin resistancenaringinobesityskeletal muscle

Identifiers

PMID36235772
PMCPMC9571698
OpenAlexW4303962166

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.